| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,400.70
|
|
Change (%)
|
2.95 (0.21%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,382.75
-
1,406.00
|
|
52-Week Range (RS)
|
1,165.55
-
1,672.20
|
|
Beta (1 Year)
|
0.58
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| Cipla allots 44,770 equity shares under ESOS |
| Indices snap 2-week gains; Nifty ends below 23,650 mark |
| Cipla to conduct AGM |
| Cipla allots 17,915 equity shares under ESOS |
| Cipla appoints President & Global Chief – Integrated Product Development |
| Board of Cipla recommends final dividend |
| Cipla consolidated net profit declines 54.61% in the March 2026 quarter |
| Cipla Q4 profit declines 55% YoY |
| Nifty May futures trade at a premium |
| Cipla gains after USFDA nod for generic albuterol inhaler |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-May-2026 |
1398.50 |
0.16 |
| 1Month |
05-May-2026 |
1333.55 |
5.04 |
| 3Month |
05-Mar-2026 |
1326.00 |
5.63 |
| 6Month |
05-Dec-2025 |
1520.55 |
-7.88 |
| 1Year |
05-Jun-2025 |
1489.65 |
-5.97 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Flexi Cap Fund |
2.74 |
2750.16 |
| Parag Parikh Flexi Cap Fund |
1.33 |
1878.56 |
| SBI Nifty 50 ETF |
0.67 |
1393.54 |
| HDFC Focused Fund |
3.49 |
914.25 |
| ICICI Pru Value Fund |
1.34 |
798.69 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,783.55 |
0.24 |
1,917.15 |
1,547.25 |
427,933.39 |
| Zydus Lifesciences Ltd |
1,088.90 |
0.32 |
1,115.00 |
835.85 |
109,568.82 |
| Dr Reddys Laboratories Ltd |
1,277.80 |
0.85 |
1,377.95 |
1,149.00 |
106,652.47 |
| Lupin Ltd |
2,268.10 |
0.86 |
2,492.00 |
1,838.65 |
103,704.91 |
| Mankind Pharma Ltd |
2,336.90 |
-0.74 |
2,726.75 |
1,909.90 |
96,492.75 |
|
|
|
|